Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safinamide for cognition in non-demented Parkinson's disease
NCT01211587Phase 2Completed
- Sponsor
- Newron Pharmaceuticals
- Start
- Sep 2010
- Primary completion
- Apr 2012
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of safinamide in Parkinson's disease (PD), sponsored by Newron Pharmaceuticals. Started Sep 2010; status: completed.
02
Drugs
safinamide
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT01211587.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01211587.